Citi Pharma Limited (PSX: CPHL)
Pakistan
· Delayed Price · Currency is PKR 43.80
-0.43 (-0.97%)
At close: Oct 11, 2024
Citi Pharma Revenue
In the fiscal year ending June 30, 2024, Citi Pharma had annual revenue of 12.41B PKR with 0.10% growth. Citi Pharma had revenue of 2.87B in the quarter ending June 30, 2024, a decrease of -5.86%.
Revenue
12.41B
Revenue Growth
+11.70%
P/S Ratio
0.81
Revenue / Employee
20.89M
Employees
594
Market Cap
10.01B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition